FDA Approves Drug to Help Curb a Tough-to-Treat Prostate Cancer

WEDNESDAY, Feb. 14, 2018 -- A new drug that can stall the progression of a particularly hard-to-treat form of prostate cancer has been approved for use by U.S. health officials. In a recent study, the drug called Erleada (apalutamide) has shown...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news